Annovis Bio (ANVS) Stock Price, Quote, News & History | Benzinga

Annovis Bio Inc (ANVS) Stock Price, Quote, News & History

ANVSNYSE

Trade with Public

Trade with Public

$1.74

-0.11-5.95%

At close: Aug 17, 5:00 PM EST

$1.79

0.052.87%

After Hours: 7:49 PM EST

Earnings: Q2 2026 Earnings were released on Fri Aug 14th, before the market open

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.82

Close

$1.74

Volume / Avg.

661.97K / 962.12K

Day Range

$1.74 - $1.85

52 Wk Range

1.54 - 5.50

Market Cap

$76.27M

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

40

Short Interest

13.4%

Days to Cover

9.45

Recent Annovis Bio Inc News

Why 8x8 Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket

Shares of 8x8 Inc (NASDAQ: EGHT) jumped 13.3% in pre-market trading after reporting better-than-expected Q4 results, with adjusted earnings of 11 cents per share and revenue of $185.25 million. GCL, PETZ, WOK, MEHA, HAO, TDIC, FEED, KELYA, and AMC were among the top gainers, while RUBI, AMIX, IPW, ANVS, and WGRX were among the top losers in pre-market trading.

Avi Kapoor

Annovis Bio Stock Jumps As New Data Shows Buntanetap Halts Cognitive Decline In Parkinson's Patients

Annovis Bio rises after Phase 3 data show buntanetap halted decline in Parkinson's patients, with results in those with amyloid co-pathology.

Vandana Singh

Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-43.34M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

44.94M

Free Cash Flow (TTM)

-43.34M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

1.60M

Analyst Trends and Forecast

1

Apr

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$55.41M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-100.57%

Earnings Yield % (FWD)

-109.20%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.10

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$18.73M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.82

Close

$1.74

Volume / Avg.

661.97K / 962.12K

Day Range

$1.74 - $1.85

52 Wk Range

1.54 - 5.50

Market Cap

$76.27M

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

40

Short Interest

13.4%

Days to Cover

9.45

About

Sector

Health Care

Industry

Biotechnology

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Annovis Bio (ANVS) stock?

A

You can purchase shares of Annovis Bio (NYSE:ANVS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Annovis Bio (ANVS) competitors?

A

Other companies in Annovis Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Annovis Bio (ANVS) stock?

A

Annovis Bio has a consensus price target of $28.00.

Q

What is the current price for Annovis Bio (ANVS)?

A

The stock price for Annovis Bio (NYSE: ANVS) is $1.79 last updated August 17, 2026 at 7:49 PM EDT.

Q

Does Annovis Bio (ANVS) pay a dividend?

A

There are no upcoming dividends for Annovis Bio.

Q

When is Annovis Bio (NYSE:ANVS) reporting earnings?

A

Annovis Bio does not have any upcoming earnings scheduled.

Q

Is Annovis Bio (ANVS) going to split?

A

There is no upcoming split for Annovis Bio.

Q

What sector and industry does Annovis Bio (ANVS) operate in?

A

Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.